Selected Abstracts from the Journal of Vascular Surgery  by unknown
Eur J Vasc Endovasc Surg (2008) 36, 616e618Selected Abstracts from the November Issue of the Journal of Vascular Surgery*Abdominal aortic coarctation: Surgical treatment of 53 patients with
a thoracoabdominal bypass, patch aortoplasty, or interposition aortoaortic
graft
James C. Stanley, Enrique Criado, Jonathan L. Eliason, Gilbert R. Upchurch,
Ramon Berguer, John E. Rectenwald
Objective: Abdominal aortic coarctation is uncommon and often compli-
cated with coexisting splanchnic and renal artery occlusive disease. This
study was undertaken to define the clinical and anatomic characteristics
of this entity, as well as the technical issues and outcomes of its operative
treatment.
Methods: Fifty-three patients, 34 males and 19 females, underwent surgical
treatment of abdominal aortic coarctations from 1963-2008 at the University
of Michigan. Patient ages in years ranged from 2e4 (n = 4), 5-8 (n = 17), 9e14
(n = 16), 15-20 (n = 11) and 25-49 (n = 5). The mean age was 11.9 years. De-
velopmental disease (n = 48), inflammatory aortitis (n = 4), and iatrogenic
trauma (n = 1) were suspected etiologies. Aortic coarctations were suprare-
nal (n = 37), intrarenal (n = 12), or infrarenal (n = 4). Patients often had co-
existing occlusive disease of the splanchnic (n = 33) and renal (n = 46)
arteries.
Results: Major clinical manifestations included: aortic and renal artery-
related secondary hypertension (n = 50), symptomatic lower extremity
ischemia (n = 3), and intestinal angina (n = 3). Primary aortic reconstructive
procedures included: thoracoabdominal bypass (n = 26), patch aortoplasty
(n = 24), or an aortoaortic interposition graft (n = 3). Primary splanchnic
(n = 19) or renal (n = 47) arterial reconstructions were performed as simulta-
neous (n = 45) or staged (n = 13) procedures in relation to the aortic surgery.
Benefits existed regarding improved control of hypertension (n = 46), as well
as elimination of extremity ischemia (n = 3) and mesenteric angina (n = 3).
Secondary renal or splanchnic arterial reoperations (n = 8) were performed
without mortality 5 days to 12 years postoperative for failed primary proce-
dures. Secondary aortic procedures, 5 to 14 years postoperative, were
performed for patch aortoplasties that became stenotic (n = 2) or aneurys-
mal (n = 1), and when thoracoabdominal bypasses developed an anastomotic
narrowing (n = 1) or proved inadequate in size with patient growth (n = 1).
No perioperative mortality accompanied either the primary or secondary
aortic reconstructive procedures.
Conclusion: Abdominal aortic coarctation represents a complex vascular
disease. Individualized treatment changed little over the period of study,
remaining dependent on the pattern of anatomic lesions, patient age, and
anticipated growth potential. This experience documented salutary
outcomes exceeding 90% following carefully performed operative therapy.Visceral aortic patch aneurysm after thoracoabdominal aortic repair:
Conventional vs hybrid treatment
Yamume Tshomba, Luca Bertoglio, Enrico M. Marone, Germano Melissano,
Roberto Chiesa
Objective: Visceral aortic patch (VAP) aneurysm repair following thoraco-
abdominal aortic aneurysm (TAAA) open treatment carries high morbidity
and mortality rates. The aim of this study is to compare the outcomes of
our series of patients who underwent redo VAP aneurysm open surgery* Full articles available online at www.jvascsurg.org
1078e5884/$34.00
doi:10.1016/S1078-5884(08)00510-8(conventional group) with a selected group of high-risk patients who under-
went, in the same time period from 2001-2007, an alternative hybrid surgical
and endovascular approach (hybrid group).
Methods: Conventional group: Twelve patients (11 males, median age 71.5
years, range, 65 to 77 years) underwent VAP aneurysm (median maximum
diameter 62 mm, range, 52 to 75 mm) repair with re-inclusion technique
via redo thoracophrenolaparotomy or bilateral subcostal laparotomy. Reim-
plantation of a single undersized VAP or separate revascularization of one or
more visceral arteries was performed. Hybrid group: Seven patients (5
males, median age 70 years, range, 63 to 78 years) defined as at high risk
for conventional surgery having American Society of Anesthesiology (ASA)
class 3 or 4 associated with a preoperative forced expiratory volume in 1
second (FEV1) <50% or an ejection fraction <40%, underwent VAP aneurysm
(median maximum diameter 73 mm, range, 62 to 84 mm) repair via median
laparotomy, visceral arteries rerouting, and VAP aneurysm exclusion using
commercially available thoracic aortic endografts.
Results: Conventional group: Perioperative mortality was 16.7% and major
morbidity 33.3%. One perioperative anuria was successfully treated with bi-
lateral renal artery stenting. No paraplegia or paraparesis were observed. At
a median follow-up of 2.3 years (range, 1.6e7 years), we observed one case
of peri-graft fluid collection with sepsis at postoperative day 46 requiring
surgical drainage and prolonged antibiotic therapy and one case of renal fail-
ure at day 68 requiring permanent hemodialysis. Hybrid group: periopera-
tive mortality was 14.3% and major morbidity 28.6% with one case of
transient delayed paraplegia. At a median follow-up of 1.9 years (range,
0.3-6.8 years), we observed one case of late pancreatitis (46 days postoper-
atively) resolved with pharmacologic treatment and one death due to an
acute visceral grafts thrombosis (78 days postoperatively). We did not ob-
serve other procedure-related deaths or complications, VAP aneurysm
growth, endoleak, and endograft migration.
Conclusion: Hybrid repair is clearly a feasible alternative to simple observa-
tion for patients unfit for redo VAP aneurysm open surgery. However, despite
our promising early results, new mid-term specific procedure-related com-
plications have been observed and a widespread use of this technique should
be currently limited until longer-term follow-up is available.National outcomes for the treatment of ruptured abdominal aortic
aneurysm: Comparison of open versus endovascular repairs
Natalia Egorova, Jeannine Giacovelli, Giampaolo Greco, Annetine Gelijns,
Craig K. Kent, James F. McKinsey
Objectives: Endovascular repair (EVAR) of ruptured abdominal aortic aneu-
rysms (rAAA) has been shown to acutely decrease procedural mortality com-
pared to open aortic repair (OAR). However, little is known about the effect
of choice of procedure; EVAR vs OAR, or the impact of physician and institu-
tion volume on long-term survival and outcome.
Methods: Patients hospitalized with rAAA who underwent either OAR or
EVAR, were derived from the Medicare In patient dataset (1995-2004) using
ICD9 codes. We evaluated long-term survival after OAR and EVAR in the en-
tire Fee-for-service Medicare population, and then in patients matched by
propensity score to create two similar cohorts for comparison with Kaplan-
Meier analysis. Annual surgeon and hospital volumes of EVAR (elective and
ruptured), OAR (elective and ruptured), and rAAA (EVAR and OAR) were di-
vided into quintiles to determine if increasing volumes correlate with de-
creasing mortality. Predictors of survival were determined by Cox modeling.
Abstracts 617Results: A total of 43,033 Medicare beneficiaries had rAAA repair: 41,969
had OAR and 1,064 had EVAR. The proportions of patients with diabetes,
hypertension, cardiovascular, cerebrovascular, renal disease, hyperlipid-
emia, and cancer were statistically higher in the EVAR than in the OAR
group, whereas lower extremity vascular disease was higher in the OAR
group. The initial evaluation of EVAR vs OAR, prior to propensity matching,
showed no statistical advantage in EVAR-survival after 90 days. The survival
analysis of patients matched by propensity score showed a benefit of EVAR
over OAR that persisted throughout the 4 years of follow-up (P = .0042). Peri-
operative and long-term survival after rAAA repair correlated with increasing
annual surgeon and hospital volume in OAR and EVAR and also with rAAA
experience. EVAR repair had a protective effect (HR = 0.857, P = .0061) on
long-term survival controlling for comorbidities, demographics, and hospital
and surgeon volume.
Conclusion: When EVAR and OAR patients are compared using a reliable
statistical technique such as propensity analysis, the perioperative survival
advantage of rAAA repaired endovascularly is maintained over the long term.
Institutional experience with rAAA is critical for survival after either OAR or
EVAR.Staging the neoaortoiliac system: Feasibility and short-term outcomes
Ahsan T. Ali, Nathan Mcleod, Venkat R. Kalapatapu, Mohammad M. Moursi,
John F. Eidt
Background: The neoaortoiliac system (NAIS) has gained popularity as a du-
rable procedure for treating aortic graft infections. However, one of the
disadvantages has been a long operation that can take up to 10 hours. The
goal of this study was to assess the feasibility of staging the NAIS procedure
with deep vein harvest a day before the aortofemoral bypass and evaluate if
staging had any effect on graft patency or morbidity and mortality, or both.
Methods: We reviewed data for all the NAIS procedures performed for aortic
graft infections at a tertiary care university hospital. The femoral popliteal
veins of patients undergoing the staged NAIS were harvested a day in
advance and left in situ. The next day patients underwent the prosthetic
graft excision with reconstruction using the femoral popliteal veins. Patients
with aortic occlusion on presentation were not candidates for vein harvest in
advance and underwent a unilateral bypass with a subsequent femorofemoral
bypass as a second stage.
Results: In the last 8 years, 26 patients (17 men, 9 women; mean age, 62.6 
8.3 years) underwent the NAIS procedure for aortic graft infections. Mean
follow-up was 15.7 months. Primary assisted graft patency was 100%. There
were 11 patients in the staged group and 10 patients in the nonstaged group.
All the staged patients underwent vein mobilization a day before excision of
aortic prosthesis. Despite undergoing a separate procedure for vein harvest-
ing at a different time, there was no difference in total operative time (12.0
1.8 vs 11.9  2.2 hours), operative blood loss (2.6  1.2 vs 3.4  2.4 L), and
requirements for transfusion for blood products (6.7  3.7 vs 6.0  5.4 U)
or crystalloid (11.3  3.1 vs 10.9  2.4 L) between the staged group and non-
staged groups. One amputation occurred in each group. The perioperative
mortality was 18% for the staged group and 20% for nonstaged group. The
12-month survival was 72% for staged and 70% for nonstaged NAIS. No graft-re-
lated complications were observed from the preoperative vein harvest.
Conclusion: The NAIS can be staged without compromising the efficacy of
the procedure as evident by excellent long-term patency and control of
the infection. By reducing the duration of the primary procedure, staging
may be beneficial to both the patient and the surgeon.Outcomes after endarterectomy for chronic mesenteric ischemia
Matthew W. Mell, Charles W. Acher, John R. Hoch, Girma Tefera, William D.
Turnipseed
Objectives: A retrospective study was performed to identify optimal factors
affecting outcomes after open revascularization for chronic mesenteric
ischemia.
Methods: All patients who underwent open surgery for chronic mesenteric
ischemia from 1987 to 2006 were reviewed. Patients with acute mesenteric
ischemia or median arcuate ligament syndrome were excluded. Mortality,
recurrent stenosis, and symptomatic recurrence were analyzed using logistic
regression, and univariate and multivariate analysis.
Results: We identified 80 patients (69% women, 31% men). Mean age was 64
years (range, 31e86 years). Acute-on-chronic symptoms were present in26%. Presenting symptoms included postprandial pain (91%), weight loss
(69%), and food fear and diarrhea (25%). Preoperative imaging demonstrated
severe (>70%) stenosis of the superior mesenteric artery in 75 patients (24
occluded), the celiac axis in 63 (20 occluded), and the inferior mesenteric
artery in 53 (20 occluded). Multivessel disease was present in 72 patients
(90%), and 40 (50%) underwent multivessel reconstruction. Revascularization
was achieved by endarterectomy in 37 patients, mesenteric bypass in 29,
and combined procedures in 14. Concurrent aortic reconstruction was
required in 13 patients (16%). Three hospital deaths occurred (3.8%). Mean
follow-up was 3.8 years (range, 0-17.2 years). One- and 5-year survival
was 92.2% and 64.5%. Mortality was associated with age (P = .019) and renal
insufficiency (P = .007), but not by clinical presentation. Symptom-free
survival was 89.7% and 82.1% at 1 and 5 years, respectively. Symptoms
requiring reintervention occurred in nine patients (11%) at a mean of 29
months (range, 5-127 months). Multivariate analysis showed that freedom
from recurrent symptoms correlated with endarterectomy for revasculariza-
tion (5.2% vs 27.6%; hazard ratio, 0.20; 95% confidence interval, 0.04-0.92;
P = .02).
Conclusion: For open surgical candidates, endarterectomy appears to pro-
vide the most durable long-term symptom relief in patients with chronic
mesenteric ischemia.Hypertensive extracorporeal limb perfusion (HELP): A new technique for
managing critical lower limb ischemia
Rodney J. Lane, Mark Phillips, Darryl McMillan, Matt Huckson, Samuel Wei-
Unn Liang, Michael Cuzzilla
Objective: The concept of repeatedly connecting an extracorporeal blood
pump to produce pancycle suprasystolic inflow pressures to ischemic limbs
is introduced. Balloon catheters allow for limb isolation from the systemic
circulation. In the acute phase, it is assumed that pressure is proportion
to flow (Poiseuille’s Law) and in the chronic phase that collateral growth
is related to endothelial shear stress and wall tension. The primary objective
was to establish that increased flow could be achieved through collateral cir-
culation in animals and in man with extracorporeal limb hyperperfusion. The
second objective was to develop and test an arterial access system capable
of intermittent regional hyperperfusion similar in concept to intermittent
hemodialysis. Finally, to demonstrate the translocation of these concepts
into humans facing major limb amputation where all standard treatment
options had been exhausted.
Methods: Twelve sheep (6 hyperperfusion and 6 controls) were attached
to a cardiac vortex pump and perfused at 200 mm Hg pancycle with
the superficial femoral artery doubly ligated and isolated from the
systemic circulation with a balloon catheter. Pressure transducers mea-
sured carotid and distal femoral pressures and the carotid-femoral index
was calculated. To allow hyperperfusion to be repeated transcutaneously,
a peripheral access system (PAS [Allvascular, St Leonards, New South
Wales, Australia]) was constructed. This device was implanted in the com-
mon carotid artery in 8 sheep and opened approximately 3 days a week
for continuous arterial access up to 37 days for 67 openings. To demon-
strate these principles in humans, 3 patients with critically ischemic limbs
were hyperperfused intermittently. Digital thermography compared the
other limb as controls and provided objective evidence of the vascular
changes.
Results: The mean carotid-femoral index was 0.6  0.01 for controls com-
pared with 1.1  0.28 for the hyperperfusion group (P < .001). The collateral
flow was superior to normal flow (ie, with the superficial femoral not oc-
cluded). Continuous access to the carotid arterial tree via the access device
was 25.3  8.8 days with 5 of 8 devices open for the entire observational pe-
riod (maximum 37 days). The human ischemic limbs were hyperperfused at
2-4 times the mean arterial pressure producing 3e6 times an increase in
pump flow measurements intermittently for 53  16 hours. The clinical find-
ings of rest pain, paresthesia, capillary return, and movement showed dra-
matic improvement as did thermographic emissions. Major amputation was
avoided in the cases presented.
Conclusion: Blood flow through collaterals can be very significantly aug-
mented by connection to an extracorporeal pump with isolation from the
systemic circulation. The pancycle hyperperfusion can be safely repeated
by implantation of an arterial access device. In the longer term, there is
evidence of collateral development. When amputation is the only alter-
native, Hypertensive Extracorporeal Limb Hyperperfusion should be
considered.
618 AbstractsThe brachial artery-brachial vein fistula: Expanding the possibilities for
autogenous fistulae
Joshua I. Greenberg, Susanne May, Ahmed Suliman, Niren Angle
Objective: The National Kidney Foundation Dialysis Outcomes and Quality
Initiative recommends autogenous access for new dialysis procedures. The
patient requiring hemodialysis with inadequate superficial arm veins repre-
sents a formidable challenge to the surgeon. Our objective is to describe
results with an alternative access procedure, the autogenous brachial-
brachial artery (ABBA) access in patients with inadequate superficial arm
veins.
Methods: One surgeon created 163 new dialysis accesses in 122 patients dur-
ing 40 consecutive months at a university hospital. There was 97% patient
follow-up. All patent but diminutive superficial arm veins as judged by
preoperative ultrasound were explored. Arms with inadequate veins at
exploration or arms with thrombosed veins on ultrasound received either
prosthetic or ABBA procedures. Upper-arm access was often staged, involv-
ing a second ‘‘superficialization’’ procedure. This is a retrospective case
series based on a comprehensive medical record review. Cox proportional
hazards models were used to compare access patency for individual as well
as multiple factors suspected or known to influence dialysis access
outcomes. Society for Vascular Surgery reporting guidelines were used
except where specifically noted and justified otherwise.
Results: One hundred thirty-five autogenous and 28 prosthetic dialysis oper-
ations were performed. Primary patency for all access procedures at 12, 24,
and 36 months was 58%, 50%, and 38%, respectively. Primary assisted pa-
tency for all access procedures at 12, 24, and 36 months was 97%, 91%,
and 85%, respectively. Secondary patency at 12, 24, and 36 months was
99%, 97%, and 97%, respectively. Finally, functional patency at 12, 24, and
36 months was 71%, 67%, and 44.0%, respectively. Of the 122 patients, 70 pa-
tients received either ABBA or prosthetic access. ABBA out-performed pros-
thetic access in terms of primary patency (hazard ratio for prosthetic vs
ABBA: 4.21 (95% confidence interval [CI]: 1.49, 11.91) and functional patency
(hazard ratio for prosthetic vs ABBA: 6.27 95% CI: 1.24-31.72) in patients
referred early. Functional patency was more likely to be compromised in
elderly patients and in patients with hypercoagulable diagnoses.
Conclusions: Autogenous brachial-brachial access for dialysis out-per-
formed prosthetic access with respect to primary and functional patency
in patients referred early without differences in overall complications.Venous stenting across the inguinal ligament
Peter Negle´n, T. Paul Tackett Jr, Seshadri Raju
Background: Arterial stenting across joints is not recommended because of
increased risk of in-stent focal neointimal hyperplasia and compression or
fracture of the stent by joint motion with decreased long-term patency.
The aim of this study was to assess the risk of placing stents in the venous
system across the inguinal ligament.
Materials and Methods: From 1997 to 2006, 177 limbs with chronic non-
malignant obstructive lesions had stents placed in the iliofemoral venous
outflow across the inguinal ligament into the common femoral vein. Transfe-
moral venograms and duplex ultrasound scans to assess cumulative patency
rates, cumulative rates, site of in-stent restenosis (ISR), and structural in-
tegrity of the stents were performed during follow-up. The results were
compared to the findings in 316 limbs with stents terminating cephalad to
the inguinal ligament.
Results: Overall cumulative secondary patency (CSP) rate at 54 months was
greater in the limbs with cephalad than in those caudad stent termination in
relation to the inguinal ligament (95% and 86%, respectively; P = .0001).
Although CSP of limbs with non-thrombotic obstruction was 100% regardless
of the site of stent termination, that of the limbs stented for thrombotic ob-
struction was greater for stents terminating cephalad than for those caudad
to the ligament (90% and 84%, respectively; P = .0378). However, a compari-
son of CSP rates between limbs treated for thrombotic occlusion and those
with thrombotic non-occlusive obstruction at 32 months revealed no differ-
ence whether or not the stent was placed across the inguinal ligament (occlu-
sion 77% and 77%, P = .7540, non-occlusive obstruction 96% and 95%, P = .7437).
Severe ISR (50%) were rare, 5%. The cumulative rate was, however, not
significantly different in limbs stented cephalad and caudad to the inguinal lig-
ament (7% and 11%, respectively, P = .6393). Focal in-stent recurrent stenosis
at the site of the inguinal ligament occurred in only 7% of limbs (all <50%).
None of the braided stainless steel stents were compressed or fractured.
Conclusion: Contrary to arterial stenting, braided stainless stents can be
safely placed in the venous system across the inguinal crease with no risk of
stent fractures, narrowing due to external compression, focal development
of severe in-stent restenosis, and no effect on long-term patency. The patency
rate is not related to the length of stented area or the placement of the stent
across the inguinal ligament, but is dependent upon the etiology and
whether the treated postthrombotic obstruction is occlusive or non-occlusive.
